Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 4,150,818 TENX shares, 9.99% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:24:26 UTC.

Accession
0000921895-26-003191
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Stake

Shares
4,150,818
Percent of class
9.99%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN03,356,85103,356,8513,356,8518.2%
BVF I GP LLCOO03,356,85103,356,8513,356,8518.2%
BIOTECHNOLOGY VALUE FUND II LPPN0769,4850769,485769,4852%
BVF II GP LLCOO0769,4850769,485769,4852%
Biotechnology Value Trading Fund OS LPPN037037370%
BVF Partners OS Ltd.CO037037370%
BVF GP HOLDINGS LLCOO04,126,33604,126,3364,126,3369.93%
BVF PARTNERS L P/ILIA,PN04,150,81804,150,8184,150,8189.99%
BVF INC/ILCO04,150,81804,150,8184,150,8189.99%
LAMPERT MARK NIN04,150,81804,150,8184,150,8189.99%